<DOC>
	<DOCNO>NCT01317888</DOCNO>
	<brief_summary>The purpose access protocol allow patient brain tumor previously receive 125I-MAB 425 receive additional course ( ) 125I-MAB 425 brain tumor begin grow , develop side effect treatment , medical condition change ( e.g. , become pregnant , become infected human immunodeficiency virus ( HIV ) develop another cancer ) .</brief_summary>
	<brief_title>Access Protocol MAB-425 Radiolabeled With I-125 High Grade Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<criteria>18 Years Older Previous treatment least one course 125IMAB 425 ( one course = 3 infusion ) Karnofsky performance status &gt; 70 % Hemoglobin &gt; 10.0 g/dL , White Blood Cells &gt; 4,000/mm3 , Platelets &gt; 100,000/mm3 , BUN &lt; 25 mg/dL , Creatinine &lt; 1.5 mg/dL Signed informed consent Pathologic confirmation GBM AAF A negative beta hCG test woman childbearing potential Negative HAMA test Metastases Second Primary Cancer Iodine allergy Inability tolerate oral intake Lugol 's solution HIV Infection Positive HAMA test Pregnancy Uncontrolled Seizures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>high grade glioma brain</keyword>
	<keyword>anti-body treatment</keyword>
	<keyword>survival</keyword>
</DOC>